Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

Haydeh Payami and colleagues report results of a genome-wide association study for Parkinson's disease. They identify common variants in the HLA region associated with the late-onset sporadic form of the disease and replicate published associations with SNCA , MAPT and GAK . Parkinson's di...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 42; no. 9; pp. 781 - 785
Main Authors Hamza, Taye H, Zabetian, Cyrus P, Tenesa, Albert, Laederach, Alain, Montimurro, Jennifer, Yearout, Dora, Kay, Denise M, Doheny, Kimberly F, Paschall, Justin, Pugh, Elizabeth, Kusel, Victoria I, Collura, Randall, Roberts, John, Griffith, Alida, Samii, Ali, Scott, William K, Nutt, John, Factor, Stewart A, Payami, Haydeh
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.09.2010
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Haydeh Payami and colleagues report results of a genome-wide association study for Parkinson's disease. They identify common variants in the HLA region associated with the late-onset sporadic form of the disease and replicate published associations with SNCA , MAPT and GAK . Parkinson's disease is a common disorder that leads to motor and cognitive disability. We performed a genome-wide association study of 2,000 individuals with Parkinson's disease (cases) and 1,986 unaffected controls from the NeuroGenetics Research Consortium (NGRC) 1 , 2 , 3 , 4 , 5 . We confirmed associations with SNCA 2 , 6 , 7 , 8 and MAPT 3 , 7 , 8 , 9 , replicated an association with GAK 9 (using data from the NGRC and a previous study 9 , P = 3.2 × 10 −9 ) and detected a new association with the HLA region (using data from the NGRC only, P = 2.9 × 10 −8 ), which replicated in two datasets (meta-analysis P = 1.9 × 10 −10 ). The HLA association was uniform across all genetic and environmental risk strata and was strong in sporadic ( P = 5.5 × 10 −10 ) and late-onset ( P = 2.4 × 10 −8 ) disease. The association peak we found was at rs3129882, a noncoding variant in HLA-DRA . Two studies have previously suggested that rs3129882 influences expression of HLA - DR and HLA-DQ 10 , 11 . The brains of individuals with Parkinson's disease show upregulation of DR antigens and the presence of DR-positive reactive microglia 12 , and nonsteroidal anti-inflammatory drugs reduce Parkinson's disease risk 4 , 13 . The genetic association with HLA supports the involvement of the immune system in Parkinson's disease and offers new targets for drug development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1061-4036
1546-1718
1546-1718
DOI:10.1038/ng.642